Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539562 · ClinicalTrials.gov registry record
Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 82
- Enrollment target
NCT03539562: Completed study, sponsored by University of California, San Francisco.
NCT03539562 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03539562 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
This will be a prospective study on labor characteristics, and obstetric and neonatal outcomes in women who accept and women who decline morphine as a form of pain management in labor. The study will also investigate patient satisfaction with this form of analgesia. The participants will be those who accept morphine and promethazine and those who decline morphine and promethazine for pain control.
Primary Outcome
Admission in active labor
Interventions
- DRUG Morphine Sulfate and Promethazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2017-09-27 |
| Est. Completion | 2020-04-01 |
What the finished NCT03539562 record still lists
NCT03539562 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Morphine Sulfate and Promethazine is the first listed.
NCT03539562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03539562 about?
NCT03539562 is a clinical study titled "Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep". This will be a prospective study on labor characteristics, and obstetric and neonatal outcomes in women who accept and women who decline morphine as a form of pain management in labor. The study will also investigate patient satisfaction with this form of analgesia. The participants will be those wh...
What is the current status of trial NCT03539562?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2017-09-27. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT03539562?
The interventions under investigation include: Morphine Sulfate and Promethazine (DRUG).
Who is sponsoring clinical trial NCT03539562?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI